Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder

Status Not yet recruiting

Clinical Trial Summary

The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their romantic partners. All participants will receive the treatment via videoconference and will complete 2 assessments. Participants with RBD will attend 7 sessions, and their partners will attend 2 of those sessions with them.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06441864
Study type	Interventional
Source	Northwestern University
Contact
Status	Not yet recruiting
Phase	N/A
Start date	July 1, 2024
Completion date	March 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03671772` - Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD
Recruiting	`NCT05109364` - Terazosin and Parkinson's Disease Extension Study	Phase 2
Recruiting	`NCT03288909` - Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease
Completed	`NCT04006925` - Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate	Phase 4
Completed	`NCT03353207` - Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for Neurodegeneration
Completed	`NCT02824341` - Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder	N/A
Recruiting	`NCT03671798` - Establish a National Registry of REM Sleep Behavior Disorder
Enrolling by invitation	`NCT01453127` - DaTSCAN Imaging in Aging and Neurodegenerative Disease	Phase 4
Terminated	`NCT02871427` - Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder	Phase 2
Completed	`NCT03595475` - Prodromal Markers of First-degree Relatives of Patients With Psychiatric Disorders Comorbid With RBD
Recruiting	`NCT03660982` - Familial Aggregation and Biomarkers in REM Sleep Behaviour Disorder.
Completed	`NCT03255642` - Efficacy and Safety of Melatonin and Clonazepam for IRBD	N/A
Recruiting	`NCT05904717` - Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder	Phase 2
Not yet recruiting	`NCT06140511` - DREAMER - IsolateD REM Sleep Without Atonia as a Risk Factor for REM Sleep Behavior disordER
Recruiting	`NCT04386317` - Terazosin Effect on Cardiac Changes in Early Parkinson's Disease	Phase 2
Enrolling by invitation	`NCT05514106` - MIBG in Aging and Neurologic Disorders	Phase 4
Completed	`NCT03645226` - Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease
Recruiting	`NCT05262543` - PREdictive Risk Factors of Conversion Into Idiopathic RBD. Italian Study
Recruiting	`NCT04071899` - French Validation of a Severity Scale in REM Sleep Behavior Disorder (SEV-TCSP)
Recruiting	`NCT04048603` - Search for Biomarkers of Neurodegenerative Diseases in Idiopathic REM Sleep Behavior Disorder